相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lung transplantation for idiopathic pulmonary fibrosis
Peter M. George et al.
LANCET RESPIRATORY MEDICINE (2019)
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
Scott D. Collum et al.
DISEASE MODELS & MECHANISMS (2019)
Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
Iwao Shimomura et al.
INTERNAL MEDICINE (2019)
Pulmonary hypertension in chronic lung disease and hypoxia
Steven D. Nathan et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension
Tamara Darwiche et al.
EXPERIMENTAL PHYSIOLOGY (2019)
Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension
Paul-Benoit Poble et al.
FASEB JOURNAL (2019)
Inflammation and immunity in IPF pathogenesis and treatment
P. Heukels et al.
RESPIRATORY MEDICINE (2019)
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease
Eniko Barczi et al.
ADVANCES IN THERAPY (2019)
Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
Mariana Faria-Urbina et al.
LUNG (2018)
Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis
Felipe Grabarz et al.
INFLAMMOPHARMACOLOGY (2018)
Emerging therapeutics in pulmonary hypertension
Matthew K. Hensley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Nintedanib in Severe Pulmonary Arterial Hypertension
Manuel J. Richter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
Andrew J. Bryant et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Targeting Hypoxia-Inducible Factor-1 alpha/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis
Justin Goodwin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Pulmonary Hypertension in Parenchymal Lung Diseases Any Future for New Therapies?
Sergio Harari et al.
CHEST (2018)
PHARMACOLOGY OF ADENOSINE RECEPTORS: THE STATE OF THE ART
Pier Andrea Borea et al.
PHYSIOLOGICAL REVIEWS (2018)
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design
Juergen Behr et al.
RESPIRATORY MEDICINE (2018)
Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension
Tinne C. J. Mertens et al.
FRONTIERS IN PHYSIOLOGY (2018)
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
Anandharajan Rathinasabapathy et al.
FRONTIERS IN PHYSIOLOGY (2018)
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
Anandharajan Rathinasabapathy et al.
FRONTIERS IN PHYSIOLOGY (2018)
Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency
Matthew T. Ratsep et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018
Gabor Kovacs et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
Gareth R. Willis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis
Sven Guenther et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodeling
Igor N. Zelko et al.
RESPIRATORY RESEARCH (2018)
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
Luca Richeldi et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Endothelial-Derived Endothelin-1 Promotes Pulmonary Vascular Remodeling in Bleomycin-Induced Pulmonary Fibrosis
A. B. Hartopo et al.
PHYSIOLOGICAL RESEARCH (2018)
Idiopathic pulmonary fibrosis: pathogenesis and management
Giacomo Sgalla et al.
RESPIRATORY RESEARCH (2018)
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial
Patrizio Vita et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1
Margaret O. James et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients
Evangelos D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension
Lucas de Mendonca et al.
STEM CELL RESEARCH & THERAPY (2017)
Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways
Agnieszka P. Grzegorzewska et al.
SCIENTIFIC REPORTS (2017)
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis
Scott D. Collum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase
Chen Liu et al.
AMERICAN JOURNAL OF HYPERTENSION (2017)
Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
Scott D. Collum et al.
CANADIAN RESPIRATORY JOURNAL (2017)
Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats
Michiel Alexander de Raaf et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension
Ning-Yuan Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension
Andrew J. Bryant et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Leukotriene B4 mediates macrophage influx and pulmonary hypertension in bleomycin-induced chronic neonatal lung injury
Mong Tieng Ee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
The role of hyaluronan in the pathobiology and treatment of respiratory disease
Stavros Garantziotis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension
Luis J. Garcia-Morales et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Targeted inhibition of Six1 attenuates allergic airway inflammation and remodeling in asthmatic mice
Zhao-Chuan Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis
Anandharajan Rathinasabapathy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Challenges and opportunities in treating inflammation associated with pulmonary hypertension
Norbert F. Voelkel et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2016)
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes
Steven C. Pugliese et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Overview
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension
Harry Karmouty-Quintana et al.
FASEB JOURNAL (2015)
Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions
Jaspreet Kalra et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2015)
Angiotensins as therapeutic targets beyond heart disease
Danielle Gomes Passos-Silva et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
Tamera J. Corte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Regulation of Hypoxia-induced Pulmonary Hypertension by Vascular Smooth Muscle Hypoxia-Inducible Factor-1α
Molly K. Ball et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Distinct Differences in Gene Expression Patterns in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis with Pulmonary Hypertension
Julia Hoffmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
R. S. Baliga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
Marlene Rabinovitch et al.
CIRCULATION RESEARCH (2014)
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
Vinayak Shenoy et al.
HYPERTENSION (2014)
Adventitial Fibroblasts Induce a Distinct Proinflammatory/Profibrotic Macrophage Phenotype in Pulmonary Hypertension
Karim C. El Kasmi et al.
JOURNAL OF IMMUNOLOGY (2014)
Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension
Bingbing Li et al.
MOLECULAR MEDICINE REPORTS (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TRANSGLUTAMINASE REGULATION OF CELL FUNCTION
Richard L. Eckert et al.
PHYSIOLOGICAL REVIEWS (2014)
Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis
Rajeev Saggar et al.
THORAX (2014)
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
Andrew R. Goudie et al.
LANCET RESPIRATORY MEDICINE (2014)
Arginase Inhibition Prevents Inflammation and Remodeling in a Guinea Pig Model of Chronic Obstructive Pulmonary Disease
T. Pera et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan A Parallel, Randomized Trial
Ganesh Raghu et al.
ANNALS OF INTERNAL MEDICINE (2013)
Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction
MeiLan K. Han et al.
CHEST (2013)
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial
Isabel Blanco et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Fiorella Calabrese et al.
PLOS ONE (2013)
Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation
Yihua Bei et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
Transglutaminase 2: A molecular Swiss army knife
Soner Gundemir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Out-of-Proportion Pulmonary Hypertension A Paradigm for Rare Diseases
Sergio Harari
CHEST (2012)
Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension
Mark L. Ormiston et al.
CIRCULATION (2012)
The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease
Harry Karmouty-Quintana et al.
FASEB JOURNAL (2012)
World Health Organization Group III pulmonary hypertension
Hooman D. Poor et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2012)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis A Tale of Angiogenesis, Apoptosis, and Growth Factors
Laszlo Farkas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Lung Extracellular Superoxide Dismutase Overexpression Lessens Bleomycin-Induced Pulmonary Hypertension and Vascular Remodeling
Zachary Van Rheen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
Samar Farha et al.
BLOOD (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Pathology of Bleomycin-Induced Fibrosis Is Associated with Loss of Resident Lung Mesenchymal Stem Cells That Regulate Effector T-Cell Proliferation
Du Jun et al.
STEM CELLS (2011)
Basic Science of Pulmonary Arterial Hypertension for Clinicians New Concepts and Experimental Therapies
Stephen L. Archer et al.
CIRCULATION (2010)
Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases
Anderson J. Ferreira et al.
HYPERTENSION (2010)
Sildenafil Therapy and Exercise Tolerance in Idiopathic Pulmonary Fibrosis
Robert M. Jackson et al.
LUNG (2010)
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
David A. Zisman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance
Eleni Papakonstantinou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22α-targeted overexpression of the serotonin transporter
Christophe Guignabert et al.
FASEB JOURNAL (2009)
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis
Masaru Iwai et al.
HYPERTENSION RESEARCH (2009)
Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease
Giuseppe Valerio et al.
Therapeutic Advances in Respiratory Disease (2009)
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Pulmonary hypertension in interstitial lung disease
J. Behr et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
A randomised, controlled trial of bosentan in severe COPD
D. Stolz et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
The role of PPARγ in pulmonary vascular disease
C. Michael Hart
JOURNAL OF INVESTIGATIVE MEDICINE (2008)
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
A. F. Shorr et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Idiopathic pulmonary fibrosis and pulmonary hypertension - Connecting the dots
Steven D. Nathan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Sildenafil improves walk distance in idiopathic pulmonary fibrosis
Harold R. Collard et al.
CHEST (2007)
HIF-dependent induction of adenosine A2B receptor in hypoxia
Tianqing Kong et al.
FASEB JOURNAL (2006)
Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus
PH Ratz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD
K Vonbank et al.
THORAX (2003)
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
HA Ghofrani et al.
LANCET (2002)
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
DC Underwood et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
分享论文
